The use of late preterm antenatal corticosteroids in women with gestational diabetes : a puzzle worth solving

Table 3 Multivariate logistic regression analysis of risk factors for composite respiratory and neonatal outcomes

Variable	Composite respiratory outcome		Composite neonatal outcome
	OR (95% CI)	p	OR (95% CI)	p
GAAB	0.36 (0.25–0.51)	< 0.01^*	0.403 (0.310–0.526)	< 0.01^*
Birthweight	1 (0.999–1.001)	0.54	1 (0.999-1)	0.28
Female gender	0.559 (0.275–1.139)	0.10	0.774 (0.474–1.264)	0.30
Vaginal delivery^#	0.426 (0.171–1058)	0.07	0.719 (0.396–1.306)	0.28
No ACT	0.912 (0.502–1.658)	0.76	0.681 (0.437–1.060)	0.09
No ACT^¥	1.123 (0.598–2.108)	0.72	0.860 (0.539–1.372)	0.53
No ACT^§	1.214 (0.638–2.311)	0.55	0.866 (0.542–1.384)	0.55

ACT, antenatal corticosteroid treatment; CI, confidence interval; GAAB, gestational age at birth; OR, relative risk
Data are expressed as median (minimum-maximum). A p value of < 0.05 indicates a significant difference. Statistically significant p-values are indicated by the superscript asterisks
^#: Antepartum and intrapartum fetal distress indicated cesarean delivery excluded
^¥: Female gender and birthweight adjusted
^§: Female gender, birthweight, maternal age and body mass index adjusted

ISSN: 1471-2393